BSP:P1KI34 (USA)
Business Description
PerkinElmer Inc
NAICS : 334516
SIC : 8071
940 Winter Street, Waltham, MA, USA, 02451
Description
PerkinElmer provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments: diagnostics, which includes immunodiagnostics, reproductive health, and applied genomics, and discovery and analytical solutions, composed of life science, industrial, environmental, and food applications. PerkinElmer offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.08 | |||||
| Equity-to-Asset | 0.51 | |||||
| Debt-to-Equity | 0.65 | |||||
| Debt-to-EBITDA | 3.13 | |||||
| Interest Coverage | 8.43 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 2.86 | |||||
| Beneish M-Score | -2.58 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 20.4 | |||||
| 3-Year EBITDA Growth Rate | 48.8 | |||||
| 3-Year EPS without NRI Growth Rate | 56 | |||||
| 3-Year FCF Growth Rate | 79.2 | |||||
| 3-Year Book Growth Rate | 34.3 | |||||
| Future 3-5Y EPS without NRI Growth Rate Industry Rank | 5.56 | |||||
| Future 3-5Y Total Revenue Growth Rate Industry Rank | -11.71 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 69.95 | |||||
| 9-Day RSI | 45.74 | |||||
| 14-Day RSI | 33.6 | |||||
| 6-1 Month Momentum % | -26.14 | |||||
| 12-1 Month Momentum % | -25.65 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.02 | |||||
| Quick Ratio | 1.42 | |||||
| Cash Ratio | 0.35 | |||||
| Days Inventory | 97.19 | |||||
| Days Sales Outstanding | 70.35 | |||||
| Days Payable | 54.46 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.21 | |||||
| Dividend Payout Ratio | 0.05 | |||||
| Forward Dividend Yield % | 0.21 | |||||
| 5-Year Yield-on-Cost % | 0.21 | |||||
| 3-Year Average Share Buyback Ratio | -4.5 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 54.31 | |||||
| Operating Margin % | 21.29 | |||||
| Net Margin % | 13.43 | |||||
| ROE % | 10.31 | |||||
| ROA % | 4.98 | |||||
| ROIC % | 6.6 | |||||
| ROC (Joel Greenblatt) % | 78.27 | |||||
| ROCE % | 8.42 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 29.57 | |||||
| Forward PE Ratio | 19.96 | |||||
| PE Ratio without NRI | 29.57 | |||||
| Shiller PE Ratio | 44.61 | |||||
| Price-to-Owner-Earnings | 23.41 | |||||
| PEG Ratio | 0.87 | |||||
| PS Ratio | 3.89 | |||||
| PB Ratio | 2.78 | |||||
| Price-to-Free-Cash-Flow | 21.26 | |||||
| Price-to-Operating-Cash-Flow | 18.84 | |||||
| EV-to-EBIT | 23.26 | |||||
| EV-to-Forward-EBIT | 20.91 | |||||
| EV-to-EBITDA | 16.23 | |||||
| EV-to-Forward-EBITDA | 16.45 | |||||
| EV-to-Revenue | 4.83 | |||||
| EV-to-Forward-Revenue | 5.25 | |||||
| EV-to-FCF | 26.57 | |||||
| Price-to-Projected-FCF | 1.42 | |||||
| Price-to-DCF (Earnings Based) | 0.78 | |||||
| Price-to-DCF (FCF Based) | 0.57 | |||||
| Price-to-Median-PS-Value | 1.2 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.19 | |||||
| Earnings Yield (Greenblatt) % | 4.3 | |||||
| Forward Rate of Return (Yacktman) % | 23.31 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Executives
EMBED
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil R$) | 26,348.029 | ||
| EPS (TTM) (R$) | 13.984 | ||
| Beta | 0 | ||
| Volatility % | 33.35 | ||
| 14-Day RSI | 33.6 | ||
| 14-Day ATR (R$) | 0.061788 | ||
| 20-Day SMA (R$) | 359.57 | ||
| 12-1 Month Momentum % | -25.65 | ||
| 52-Week Range (R$) | 345.19 - 553.64 | ||
| Shares Outstanding (Mil) | 252.45 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
PerkinElmer Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||